Winning of the Feburic patent trial neutralized sales prohibition of generics
As companies which sell generics of ‘Feburic Tab(SK Chemicals, febuxostat),’ a gout treatment, won the patent suit, they neutralized the sales prohibition action. Thus, commercialization of the generic products, which has been delayed due to the action, will also be made soon.
Previously, SK Che...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
